Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$11.81 - $20.92 $105,109 - $186,188
-8,900 Reduced 15.38%
48,973 $656,000
Q1 2022

May 10, 2022

BUY
$16.97 - $25.0 $634,678 - $935,000
37,400 Added 182.68%
57,873 $1.12 Million
Q3 2021

Nov 09, 2021

BUY
$16.0 - $28.84 $327,568 - $590,441
20,473 New
20,473 $410,000

Others Institutions Holding IMGO

About Imago BioSciences, Inc.


  • Ticker IMGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,741,600
  • Description
  • Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...
More about IMGO
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.